PEER REVIEWED, EVIDENCE-BASED INFORMATION FOR CLINICIANS AND RESEARCHERS IN NEUROSCIENCE

Tag: Levomilnacipran

Anxiety Disorders

Serotonin Norepinephrine Reuptake Inhibitors: A Pharmacological Comparison

by Randy A. Sansone, MD, and Lori A. Sansone, MD

April 21, 2014 No Comments

Mental Disorders

A Randomized, Double-blind, Placebo-controlled Trial of the Efficacy and Safety of Levomilnacipran ER 40–120mg/day for Prevention of Relapse in Patients with Major Depressive Disorder

by Thomas Shiovitz, MD; William M. Greenberg, MD; Changzheng Chen,

February 3, 2014 No Comments

LATEST DIGITAL EDITION

ARCHIVES

Innovations in Clinical Neuroscience is a subsidiary of Matrix Medical Communications

contact

Links

About

Topics

© 2025 Matrix Medical Communications copyright all rights reserved.